RHOA and breast cancer: Furthermore, stimulation of endogenous G12 signaling by thrombin, which activates the G12-coupled protease-activated receptor (PAR-1) [29], led to JNK and c-Jun activation in breast cancer cells in a manner that was inhibited by expression of DN RhoA (Figure 3A).